Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Other Working Capital | -248,000 | -37,000 | -47,000 | -167,680 | 336,000 |
| Other Operating Activity | 248,000 | 37,000 | 47,000 | 167,680 | -336,000 |
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 200,000 | -225,000 | -144,000 | -201,280 | -254,000 |
| Net Acquisitions | -306,000 | N/A | N/A | 240 | -5,000 |
| Purchase Of Investment | -6,000 | -70,000 | -1,000 | N/A | -7,000 |
| Sale Of Investment | 18,000 | N/A | N/A | N/A | 19,000 |
| Other Investing Activity | -164,000 | 40,000 | 0 | -214,520 | 5,000 |
| Investing Cash Flow | $-258,000 | $-255,000 | $-145,000 | $-415,560 | $-242,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 52,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 25,000 | N/A | N/A | 14,880 | 8,000 |
| Common Stock Repurchased | -247,000 | N/A | N/A | N/A | N/A |
| Dividend Paid | -1,092,000 | N/A | N/A | -520,160 | -523,000 |
| Other Financing Activity | 1,035,000 | 1,229,000 | -1,325,000 | -2,732,880 | 156,000 |
| Financing Cash Flow | $-227,000 | $1,229,000 | $-1,325,000 | $-3,238,160 | $-359,000 |
| Exchange Rate Effect | 3,000 | 28,000 | -47,000 | N/A | N/A |
| Beginning Cash Position | 2,298,000 | 1,411,000 | 1,831,000 | -1,442,000 | N/A |
| End Cash Position | 2,045,000 | 2,298,000 | 1,411,000 | 960,960 | -1,442,000 |
| Net Cash Flow | $-256,000 | $859,000 | $-373,000 | $-919,880 | $720,000 |
| Free Cash Flow | |||||
| Capital Expenditure | N/A | -239,000 | -144,000 | -218,000 | -255,000 |
| Free Cash Flow | 0 | -239,000 | -144,000 | -218,000 | -255,000 |